Does pravastatin affect circulating levels of soluble TNF receptor 2 in hypercholesterolemic patients?

被引：4

作者：

Ando, H

Takamura, T

Kobayashi, K

Misu, H

Osawa, K

机构：

[1] Kanazawa Univ, Grad Sch Med Sci, Dept Endocrinol & Metab, Kanazawa, Ishikawa 9208641, Japan

[2] Tonami Gen Hosp, Dept Endocrinol, Tonami 9391395, Japan

来源：

ATHEROSCLEROSIS | 2003年 / 166卷 / 02期

关键词：

D O I：

10.1016/S0021-9150(02)00378-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：413 / 414

页数：2

共 9 条

[1] STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS [J].

ADERKA, D ;

ENGELMANN, H ;

MAOR, Y ;

BRAKEBUSCH, C ;

WALLACH, D .

JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :323-329

[2]

Ando H, 2000, J PHARMACOL EXP THER, V294, P1043

[3] Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: No clear relationship with levels of tumor necrosis factor [J].

Blann, AD ;

McCollum, CN .

INFLAMMATION, 1998, 22 (05) :483-491

[4] Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance [J].

Fernández-Real, JM ;

Broch, M ;

Ricart, W ;

Casamitjana, R ;

Gutierrez, C ;

Vendrell, J ;

Richart, C .

DIABETES, 1998, 47 (11) :1757-1762

[5]

Freeman DJ, 2001, CIRCULATION, V103, P357

[6] ADIPOSE EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA - DIRECT ROLE IN OBESITY-LINKED INSULIN RESISTANCE [J].

HOTAMISLIGIL, GS ;

SHARGILL, NS ;

SPIEGELMAN, BM .

SCIENCE, 1993, 259 (5091) :87-91

[7] INCREASED ADIPOSE-TISSUE EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA IN HUMAN OBESITY AND INSULIN-RESISTANCE [J].

HOTAMISLIGIL, GS ;

ARNER, P ;

CARO, JF ;

ATKINSON, RL ;

SPIEGELMAN, BM .

JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2409-2415

[8] Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages [J].

Pahan, K ;

Sheikh, FG ;

Namboodiri, AMS ;

Singh, I .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11) :2671-2679

[9] Reduced levels of TNFα in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks [J].

Solheim, S ;

Seljeflot, I ;

Arnesen, H ;

Eritsland, J ;

Eikvar, L .

ATHEROSCLEROSIS, 2001, 157 (02) :411-415

← 1 →